Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identifying anti-cancer drug response related genes using an integrative analysis of transcriptomic and genomic variations with cell line-based drug perturbations.

Oncotarget - 23 Feb 2016

Sun Yi, Zhang Wei, Chen Yunqin, Ma Qin, Wei Jia, Liu Qi

Abstract excerpt

BACKGROUND: Clinical responses to anti-cancer therapies often only benefit a defined subset of patients. Predicting the best treatment strategy hinges on our ability to effectively translate genomic data into actionable information on drug responses. RESULTS: To achieve this goal, we compiled a comprehensive collection of baseline cancer genome data and drug response information derived from a large panel of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Algorithms
Share to Antineoplastic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Carcinoma, Non-Small-Cell Lung

Share to Drug Resistance, Neoplasm

Share to Models, Theoretical

Share to Oligonucleotide Array Sequence Analysis

Share to Skin Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 26824188
DOI: 10.18632/oncotarget.7012
PMCID: PMC4891048

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identifying anti-cancer drug response related genes using an integrative analysis of transcriptomic and genomic variations with cell line-based drug perturbations.PMID 26824188Read ↗

Predicting drug response from single-cell expression profiles of tumoursSemantic proximity Read ↗

scDrugAtlas: an integrative single-cell drug response database for dissecting tumor heterogeneity in therapeutic efficacySemantic proximity Read ↗

Data Mining Approaches for Genomic Biomarker Development: Applications Using Drug Screening Data from the Cancer Genome Project and the Cancer Cell Line Encyclopedia.Semantic proximity Read ↗

Interactive webtool for analyzing drug sensitivity and resistance associated with genetic signatures of cancer cell linesSemantic proximity Read ↗

Deep learning-driven drug response prediction and mechanistic insights in cancer genomicsSemantic proximity Read ↗

Multi-omics alleviates the limitations of panel-sequencing for cancer drug response predictionSemantic proximity Read ↗

Predicting Tumor Response to Drugs based on Gene-Expression Biomarkers of Sensitivity Learned from Cancer Cell LinesSemantic proximity Read ↗

Predicting Tumor Response to Drugs Based on Gene-expression Biomarkers of Sensitivity Learned From Cancer Cell LinesSemantic proximity Read ↗

Rationalizing Drug Response in Cancer Cell Lines.Semantic proximity Read ↗

Cell line modeling for systems medicine in cancers (Review)Semantic proximity Read ↗

Dr.Paso: Drug response prediction and analysis system for oncology researchSemantic proximity Read ↗

Gene expression based inference of drug resistance in cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.